Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF

Pre‐analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF

Abstract Introduction We aimed to establish a standardized, routine‐use pre‐analytical protocol for measuring Alzheimer's disease (AD) biomarkers in cerebrospinal fluid (CSF). Methods The effect of pre‐analytical factors (sample collection/handling/storage/transportation) on biomarker levels wa...

Full description

Bibliographic Details
Main Authors: Oskar Hansson, Sandra Rutz, Henrik Zetterberg, Ekaterina Bauer, Teresa Hähl, Ekaterina Manuilova, Mehmet Can Mert, Simone Wahl, Kaj Blennow, Erik Stomrud
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
amyloid beta
biomarker
cerebrospinal fluid
diagnosis
pre‐analytical
Online Access:https://doi.org/10.1002/dad2.12137

Internet

https://doi.org/10.1002/dad2.12137

Similar Items